Impact of the Assisted Ventilation Mode on Diaphragm Efficiency in Critically Ill Patients
NAVA_PSV
Impact of Pressure Support Ventilation (PSV) Versus Neurally Adjusted Ventilatory Assist (NAVA) Diaphragm Efficiency
1 other identifier
interventional
38
1 country
1
Brief Summary
This study evaluates the impact of the assisted mode of mechanical ventilation on diaphragm efficiency in mechanically ventilated critically ill patients. Participants will be randomized to the neurally adjusted ventilatory assist (NAVA) mode or to the pressure support ventilation (PSV) mode.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started May 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2015
CompletedFirst Submitted
Initial submission to the registry
June 8, 2015
CompletedFirst Posted
Study publicly available on registry
June 16, 2015
CompletedJune 16, 2015
June 1, 2015
1 year
June 8, 2015
June 11, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diaphragm neuro-ventilatory efficiency (NVE)
Diaphragm neuro-ventilatory efficiency (NVE) to convert the electrical diaphragm activity (EAdi) into volume. NVE is impaired by controlled mechanical ventilation (CMV) and the assisted mode should serve to restore it. All the studied patents were ventilated for more than 48 hours in CMV, a period shown to be sufficient to induce diaphragm atrophy and therefore depress NVE. NVE is measured by the ratio between tidal volume (VT) and the EAdi peak (NVEpeak) or by the ratio between VT and the are under the EAdi signal. EAdi is obtained by the EAdi catheter, a nasogastric catheter equipped with electrodes (Maquet Critical Care, Solna, Sweden). EAdi is measured in microVolt. The Servo i ventilator (Maquet Critical Care, Solna Sweden) is equipped with a module able to amplify and show on a screen the EAdi trace and the corresponding value. Both the Servo i ventilator and the EAdi catheter are approved for clinical use.
48 hours
Secondary Outcomes (1)
Diaphragm neuro-mechanical efficiency (NME)
48 hours
Study Arms (2)
Pressure Support Ventilation
EXPERIMENTALAssisted mechanical ventilation
Neurally Adjusted Ventilatory Assist
EXPERIMENTALAssisted mechanical ventilation
Interventions
Assisted mechanical ventilation
Eligibility Criteria
You may qualify if:
- older than 18 years
- oro-tracheally or naso-tracheally intubate
- had been ventilated for acute respiratory failure in control mechanical ventilation for at least 72 hours consecutively
- candidate to assisted ventilation
- Hemodynamically stable without vasopressor or inotropes (excluding a dobutamine and dopamine infusion lower than 5 gamma/Kg/min and a 3 gamma /Kg/min, respectively
- normothermia
You may not qualify if:
- Neurological or neuromuscular pathologies
- phrenic nerve dysfunction
- contraindications to the insertion of a nasogastric tube (for example recent upper gastrointestinal surgery, esophageal varices).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Azienda Ospedaliero Universitaria Policlinico
Bari, 70124, Italy
Related Publications (1)
Di Mussi R, Spadaro S, Mirabella L, Volta CA, Serio G, Staffieri F, Dambrosio M, Cinnella G, Bruno F, Grasso S. Impact of prolonged assisted ventilation on diaphragmatic efficiency: NAVA versus PSV. Crit Care. 2016 Jan 5;20:1. doi: 10.1186/s13054-015-1178-0.
PMID: 26728475DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Salvatore Grasso, Prof
University of Bari
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
June 8, 2015
First Posted
June 16, 2015
Study Start
May 1, 2013
Primary Completion
May 1, 2014
Study Completion
May 1, 2015
Last Updated
June 16, 2015
Record last verified: 2015-06